Status:
COMPLETED
Study of the Spermatic Characteristics of Patients With Fabry Disease
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Fabry Disease
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
The objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.The main objective of this project is to estimate the prevalence of spermatic abno...
Detailed Description
Fabry disease is a lysosomal storage burden of X-linked genetic transmission due to alpha-galactosidase deficiency. This enzyme deficiency causes deposits of globotriaosylceramide in virtually all cel...
Eligibility Criteria
Inclusion
- male patients with Fabry disease regardless of the clinical form of the disease; treated with enzyme replacement therapy or not (from the initial diagnosis). The definite diagnosis of Fabry disease will be established on the deficit of the activity of alpha galactosidase A (\<12%). A molecular genetic study is desirable but not mandatory,
- patients aged 18 to 65,
- giving their free and informed consent to participate, after information on the research.
Exclusion
- persons placed under the protection of justice,
- unaffiliated or non-beneficiary subject of a social security scheme.
Key Trial Info
Start Date :
February 20 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2013
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04073888
Start Date
February 20 2009
End Date
October 18 2013
Last Update
August 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.